We are live on ! Find out more
LOXO

Loxo Oncology, Inc
LOXO

Delisted

LOXO was delisted on the 14th of February, 2019.

67 hedge funds and large institutions have $504M invested in Loxo Oncology, Inc in 2016 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 27 increasing their positions, 16 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

69% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 16

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

0% more capital invested

Capital invested by funds: $502M → $504M (+$1.62M)

8% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 13

1% less funds holding

Funds holding: 6867 (-1)

Holders
67
Holders Change
-1
Holders Change %
-1.47%
% of All Funds
1.79%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.11%
New
12
Increased
27
Reduced
16
Closed
13
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Citigroup
51
Citigroup
New York
$209K +$99.7K +4,765 +166%
MLICM
52
Metropolitan Life Insurance Company (MetLife)
New York
$191K
Manulife (Manufacturers Life Insurance)
53
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$157K +$27.9K +1,335 +28%
NFA
54
Nationwide Fund Advisors
Ohio
$154K -$565 -27 -0.5%
Wells Fargo
55
Wells Fargo
California
$133K +$2.99K +143 +3%
AIG
56
American International Group
New York
$125K
BA
57
BlackRock Advisors
Delaware
$114K -$361K -17,239 -81%
Bank of America
58
Bank of America
North Carolina
$55K +$2.72K +130 +7%
Morgan Stanley
59
Morgan Stanley
New York
$49K -$311K -14,861 -89%
JP Morgan Chase
60
JP Morgan Chase
New York
$20K +$4K +191 +36%
UBS Group
61
UBS Group
Switzerland
$13K +$10.1K +485 New
BlackRock
62
BlackRock
New York
$9K +$6.72K +321 New
AIM
63
Advantage Investment Management
Iowa
$8K
GT
64
Glenmede Trust
Pennsylvania
$7K
Bank of Montreal
65
Bank of Montreal
Ontario, Canada
$5K +$2.3K +110 +155%
TRCT
66
Tower Research Capital (TRC)
New York
$5K +$4.18K +200 New
Geode Capital Management
67
Geode Capital Management
Massachusetts
$1.56K +$44.5K +2,126 +4%
VAM
68
Visium Asset Management
New York
-$11.4M -400,000 Closed
SFM
69
Sphera Funds Management
Israel
-$1.28M -45,000 Closed
Balyasny Asset Management
70
Balyasny Asset Management
Illinois
-$784K -27,550 Closed
Citadel Advisors
71
Citadel Advisors
Florida
-$726K -25,501 Closed
Renaissance Technologies
72
Renaissance Technologies
New York
-$592K -20,800 Closed
Two Sigma Investments
73
Two Sigma Investments
New York
-$578K -20,324 Closed
SIM
74
Spark Investment Management
New York
-$534K -18,800 Closed
PP
75
PDT Partners
New York
-$422K -14,831 Closed

LOXO Hedge Fund Activity: Q1 2016 in Review

67 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q1 2016, worth a combined $504M — up 0.32% from $502M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of LOXO and 12 opened new positions — a net loss of 1 holder — while 16 trimmed existing stakes and 27 added.

The largest buyer was Wellington Management Group, opening a new position worth an estimated $10.3M. The largest seller was BVF Inc, cutting an estimated $13.3M.

  • 67 institutional investors held Loxo Oncology, Inc (LOXO) as of Q1 2016, down from 68 in Q4 2015.
  • Funds reported $504M of Loxo Oncology, Inc stock for Q1 2016, up 0.32% quarter-over-quarter.
  • 12 funds opened new Loxo Oncology, Inc positions in Q1 2016 and 13 closed out, a net change of -1 holder.
  • The largest Loxo Oncology, Inc buyer in Q1 2016 was Wellington Management Group, an estimated $10.3M added.
  • The largest Loxo Oncology, Inc seller in Q1 2016 was BVF Inc, an estimated $13.3M sold.

Based on aggregated 13F filings for Q1 2016.